Answer
It can be either: the nasal product is an antidepressant treatment, while the injectable product is an anaesthetic and analgesic.
Sources for this answer
- Spravato 28 mg nasal spray, solution — Current selected SmPCemc · Summary of Product Characteristics
- Esketamine 25 mg/ml solution for injection/infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.